Heterocycles with Nitrogen (N)

1-(2-Chlorophenyl)piperazine is a chloroquine-resistant anti-malarial drug that acts by inhibiting the enzyme dihydropteroate synthase. This method is efficient, with constant values for the vibrational energy and electron affinity. It has also been shown to be effective against 5-HT2C receptors in mammalian cells in culture. The chromatographic method was used to measure the affinity of 1-(2-chlorophenyl)piperazine for binding sites on plasma membranes of oocytes injected with Xenopus laevis. Fluorescence measurements were taken to determine the binding affinity of 1-(2-chlorophenyl)piperazine to arylpiperazines, which are fluorescent analogues of piperazines. Functional theory was used as a theoretical basis for this study.

6-Ethylmercaptopurine is a purine analogue that inhibits the synthesis of DNA. It is used as an inhibitor of protein synthesis and in the treatment of inflammatory bowel disease. 6-Ethylmercaptopurine has been shown to inhibit the activity of ATPase, which may be responsible for its ability to suppress the proliferation of cells. This drug can also act as an analog to adenosine, which can be used to determine ATP levels in a cell or tissue sample by measuring the amount of p-nitrophenyl phosphate produced. 6-Ethylmercaptopurine has been shown to block phosphatase activity, which may lead to inflammation in some cases.
6-Ethylmercaptopurine has a molecular weight of 194.2 g/mol and an optimum pH of 4.5

1-(2-Pyridinyl)benzotriazole is a reagent that is used as an intermediate for the preparation of complex compound. It also has other uses such as a building block and scaffold in the synthesis of fine chemicals, research chemicals, and versatile building blocks. 1-(2-Pyridinyl)benzotriazole can be used in reactions with other chemical compounds to form useful intermediates.

4,4'-Bis(methoxycarbonyl)-2,2'-bipyridine is a ligand that can be used in cross-coupling reactions. It has been shown to bind to metal ions and form complexes with the ligands. 4,4'-Bis(methoxycarbonyl)-2,2'-bipyridine has a constant value for maximizing the yield of the reaction and is luminescent. This product also has photophysical properties that allow it to be utilized in voltammetry studies. The transfer of this product can be optimized by using chromophores or catalysis. 4,4'-Bis(methoxycarbonyl)-2,2'-bipyridine provides a means for cross-coupling reactions using electrochemical studies and dichroism.

2-Amino-4,6-dihydroxypyrimidine is a chemical compound that is used in the synthesis of pemetrexed. It has been shown to inhibit the growth of cancer cells in cell culture by cross-coupling with nitrogen atoms in DNA and thereby inhibiting replication. 2-Amino-4,6-dihydroxypyrimidine also reacts with halides to form reaction intermediates that are capable of reacting with hydrogen bonds and other functional groups. This chemical compound has been shown to have radical scavenging activities in acidic environments and vibrational properties.

6-Amino-2-pyrazinecarboxylic acid is a high quality reagent that is used as an intermediate for the synthesis of complex compounds. It is also a useful scaffold for the production of valuable speciality chemicals. This chemical is also used as a reaction component in research and development to produce versatile building blocks. 6-Amino-2-pyrazinecarboxylic acid has been shown to be useful for producing fine chemicals and speciality chemicals, which are often used in many industries.

5-Bromo-1H-indazole-3-carbonitrile is a high quality, versatile building block that can be used in the synthesis of complex compounds. It has been described as a "useful intermediate" and a "useful scaffold".

4-Amino-2,6-dichloro-3-nitropyridine is a synthetic compound that inhibits tyrosine kinases. It is an isomer of 2,6-Dichloropyridine and has been shown to inhibit the growth of lymphoma cells in vitro. 4-Amino-2,6-dichloro-3-nitropyridine has three substitutions on the pyridine ring as compared to 2,6-Dichloropyridine. The substitutions are thought to be responsible for the increased hydrophilic properties of this compound. This may lead to increased cellular uptake and better bioavailability.

5-Nitro-7-azaindole is a heterocyclic compound that is structurally related to the furoquinolines. It has been shown to act as an inhibitor of benzene and pyridine oxidases, which are enzymes that catalyze the conversion of these compounds into reactive intermediates. The reaction mechanism of 5-Nitro-7-azaindole with benzene and pyridine oxidases involves the formation of covalent bonds with reactive sulfur atoms in the enzyme active site. 5-Nitro-7-azaindole also inhibits bacterial growth by inhibiting DNA synthesis. This compound has been found to be scalable and can be produced at large scales without loss in quality. 5-Nitro-7-azaindole is not stereoselective and it is not an aromatic system, meaning that it does not have a benzene ring.

2,6-Pyridinedicarboxylic acid dimethyl ester is a drug that has shown anticancer activity in animal models. It binds to DNA, forming a ternary complex with the DNA and the enzyme topoisomerase I. The binding of this drug to the enzyme prevents it from breaking the DNA strands during replication, causing the cell to die. It has been shown that 2,6-pyridinedicarboxylic acid dimethyl ester can be used as a non-competitive inhibitor of topoisomerase I. Furthermore, it has been demonstrated that 2,6-pyridinedicarboxylic acid dimethyl ester is able to bind to human endometrial cancer cells with high affinity. Finally, 2,6-pyridinedicarboxylic acid dimethyl ester was found in x-ray crystal structures of complexes with hydrogen bonds and low activation enthalpy and entropy.

2,6-Dibromopyrazine is a quinoxaline molecule with two nitrogen atoms. It is an electropolymerizable material that can be used to create patterned surfaces. 2,6-Dibromopyrazine has been used in the fabrication of devices such as fluorescent lamps and light emitting diodes (LEDs). The fluorescence of these devices depends on the alignment of molecules within the device. The number and position of nitrogen atoms in the molecule determine the wavelength emission. 2,6-Dibromopyrazine is a structural isomer of 1,8-dibromopyrazine.
2,6-Dibromopyrazine has homologues such as anilines and amines that have been used in organic synthesis for decades.

2-Amino-6-iodopurine is an analog of the purine nucleoside guanine, which has been used to synthesize a variety of boronic acids. The most common use for 2-amino-6-iodopurine is in the synthesis of benzylboronic acid, which can be used as an organometallic reagent in organic synthesis. This compound also has dehydrogenase activity and has been shown to catalyze the conversion of benzoic acid to benzaldehyde, mediated by NADH. 2-Amino-6-iodopurine is found in the biosynthesis of ribonucleotides and deoxyribonucleotides, where it reacts with chloride ions and phosphate groups to form adenylate and xanthosine monophosphates.

3,5,6-Trichloro-4-hydroxy-2-picolinic acid is a high quality reagent that is used as a building block for the synthesis of complex compounds with potential pharmaceutical applications. It can be used as an intermediate in the production of fine chemicals and speciality chemicals. This compound is also useful for research purposes and as a versatile building block for reactions.

2,4-Pyridinedicarboxylic acid diethyl ester is an aliphatic hydrocarbon that has been shown to be a potent active oxygen scavenger. It has also been shown to inhibit the uptake of fatty acids and organic anions by tubule cells in the liver, as well as to reduce collagen breakdown in the endoplasmic reticulum. This compound is converted into pyridinedicarboxylic acid, which inhibits hepcidin production and thus increases iron absorption. 2,4-Pyridinedicarboxylic acid diethyl ester also has a biochemical profile that is similar to that of a lipophilic fatty acid ester.

4,6-Dihydroxypyrazolo[3,4-d]pyrimidine is a xanthine derivative that is used as a therapeutic agent. It has inhibitory properties against xanthine oxidase and other enzymes. 4,6-Dihydroxypyrazolo[3,4-d]pyrimidine inhibits the activity of xanthine oxidase by covalent bonding to the iron atom in the enzyme's active site. This binding prevents the conversion of hypoxanthine to xanthine and subsequently prevents the conversion of xanthine to uric acid. The resulting accumulation of hypoxanthine can lead to bowel disease. 4,6-Dihydroxypyrazolo[3,4-d]pyrimidine has also been shown to be toxic when administered orally in large doses or injected intravenously in small doses because it binds to matrix proteins and causes epidermal necrosis.

4-Chloro-1H-imidazole is an organic chemical compound that contains a heterocyclic ring with one nitrogen and three carbons. It is classified as a weak acid. 4-Chloro-1H-imidazole can be found in hydrochloric acid, methyl ketones, and the acid conjugates of pyrazole rings. It has minimal toxicity. 4-Chloro-1H-imidazole binds to receptors in the body, which may account for its effects on blood pressure and heart rate. This drug also reacts with diazonium salts to form an intermediate that is then oxidized by chloride ions to form a reactive intermediate that can react with histidine or flavin (a type of vitamin B2) to form a fluorescent product that can be detected by light absorption or fluorescence emission spectroscopy.

3-(Diethylboryl) pyridine is a halogenated biphenyl. It is used in the synthesis of 3-aryl substituted pyridines by cross-coupling reactions with aryl iodides, bromides and chlorides. Cross-coupling reactions are usually carried out at low temperatures (0 to 20°C) in order to minimize side reactions. The reaction is usually conducted in a biphasic system containing an organic solvent and water, which facilitates the extraction of the product from the mixture. 3-(Diethylboryl) pyridine reacts with halide ions via an electrophilic substitution reaction to form a reactive intermediate, which reacts with palladium catalyst to produce the desired product. This process is also called catalytic hydrogenation. 3-(Diethylboryl) pyridine has been shown to inhibit human cytochrome P450 enzymes, which are involved in drug metabolism and break down drugs